2015


Zürich

Homepage

Company profile

PharmaBiome AG

Until now, faecal transplants were the only way to treat an intestinal infection. However, since this form of treatment risks transmission of a disease, it is used only if the condition is life-threatening. As an alternative, ETH Zurich spin-off and Venture Kick winner PharmaBiome is developing a mix of healthy gut bacteria to restore the patient’s intestinal flora.


Source: startup.ch

Highlights

More news about PharmaBiome AG

23.03.2018 11:53

Ein Startup gewinnt den Spark Award

Award
Please login or
register to use the
bookmark feature
14.06.2016 14:41

130‘000 Franken für PharmaBiome

Award
Please login or
register to use the
bookmark feature
06.04.2016 16:45

Venturelab presents the 20 Venture leaders of 2016

AwardSupport
Please login or
register to use the
bookmark feature

By continuing to use this website you agree with our TERMS AND CONDITIONS